Insider Trading activities of Calithera Biosciences, Inc. (CALA)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Calithera Biosciences, Inc. (CALA) since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Calithera Biosciences, Inc. since year 2005. Table 2 shows the detailed insider transactions of Calithera Biosciences, Inc. since 2005. The reporting company's ticker symbol is CALA. The reporting company's CIK number is 1496671.
The total value of stock buying since 2005 is $46,334,802.
The total value of stock sales since 2005 is $9,185,799.
The total value of stock option exercises since 2005 is $639,030.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Calithera Biosciences, Inc. (CALA).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2019-06 103,200 $400,416 417 $2,502 37,985 $63,758
2019-05 0 $0 416 $2,496 0 $0
2019-04 0 $0 416 $2,633 0 $0
2019-03 0 $0 1,982 $12,071 0 $0
2018-10 0 $0 1,565 $9,405 0 $0
2018-04 0 $0 0 $0 16,810 $8,068
2018-03 0 $0 0 $0 33,790 $89,204
2018-02 0 $0 0 $0 15,095 $31,291
2017-12 0 $0 0 $0 22,070 $39,725
2017-09 0 $0 576,000 $9,008,100 0 $0
2017-07 0 $0 6,372 $116,808 0 $0
2017-05 0 $0 650 $10,400 0 $0
2017-03 487,804 $4,999,991 1,150 $15,000 0 $0
2016-12 0 $0 0 $0 32,100 $57,779
2016-11 500,000 $1,575,000 0 $0 0 $0
2016-07 0 $0 0 $0 41,720 $62,166
2015-12 0 $0 0 $0 48,405 $61,890
2015-11 0 $0 970 $6,384 0 $0
2015-09 197,268 $1,180,170 0 $0 0 $0
2015-08 172,126 $911,972 0 $0 2,000 $5,280
2015-07 0 $0 0 $0 132,152 $186,428
2014-12 0 $0 0 $0 6,797 $33,441
2014-10 3,781,700 $37,267,253 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Calithera Biosciences, Inc. insiders (CALA)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2019-06-25 Molineaux Christopher (SR. VP, DEVELOPMENT) Buy 51,600 3.88 200,208
2019-06-25 Molineaux Susan (PRESIDENT AND CEO) Buy 51,600 3.88 200,208
2019-06-24 Sjogren Eric (SR. VP, DRUG DISCOVERY) Option Ex 21,739 .96 20,869
2019-06-19 Wong Stephanie (SR. VP, FINANCE & SECRETARY) Option Ex 10,000 2.64 26,400
2019-06-17 Parlati Francesco (VP, RESEARCH) Option Ex 6,246 2.64 16,489
2019-06-17 Orford Keith (Chief Medical Officer) Sale 417 6.00 2,502
2019-05-22 Orford Keith (Chief Medical Officer) Sale 416 6.00 2,496
2019-04-15 Orford Keith (Chief Medical Officer) Sale 416 6.33 2,633
2019-03-15 Orford Keith (Chief Medical Officer) Sale 417 6.43 2,681
2019-03-11 Orford Keith (Chief Medical Officer) Sale 1,565 6.00 9,390
2018-10-15 Orford Keith (SR. VP, CLINICAL DEVELOPMENT) Sale 313 6.05 1,893
2018-10-11 Orford Keith (SR. VP, CLINICAL DEVELOPMENT) Sale 1,252 6.00 7,512
2018-04-03 Sjogren Eric (SR. VP, DRUG DISCOVERY) Option Ex 16,810 .48 8,068
2018-03-02 Molineaux Christopher (SR. VP, DEVELOPMENT) Option Ex 6,798 2.64 17,946
2018-03-02 Molineaux Susan (PRESIDENT AND CEO) Option Ex 26,992 2.64 71,258
2018-02-23 Wong Stephanie (SR VP, FINANCE AND SECRETARY) Option Ex 10,000 2.64 26,400
2018-02-20 Parlati Francesco (VP, RESEARCH) Option Ex 5,095 .96 4,891
2017-12-05 Molineaux Christopher (SR. VP, DEVELOPMENT) Option Ex 9,202 1.80 16,563
2017-12-05 Molineaux Susan (PRESIDENT AND CEO) Option Ex 12,868 1.80 23,162
2017-09-28 Gross Phillip Sale 38,000 15.50 589,000
2017-09-27 Gross Phillip Sale 186,000 15.59 2,899,740
2017-09-26 Gross Phillip Sale 352,000 15.68 5,519,360
2017-07-17 Orford Keith (SR. VP, CLINICAL DEVELOPMENT) Sale 2,120 18.31 38,823
2017-07-17 Wong Stephanie (VP, FINANCE AND SECRETARY) Sale 3,552 18.41 65,385
2017-07-06 Hecht Curtis (SVP, BUS. & CORP. DEVELOPMENT) Sale 700 18.00 12,600
2017-05-19 Hecht Curtis (SVP, BUS. & CORP. DEVELOPMENT) Sale 650 16.00 10,400
2017-03-22 Gross Phillip Buy 487,804 10.25 4,999,991
2017-03-13 Hecht Curtis (SVP, BUS. & CORP. DEVELOPMENT) Sale 600 14.00 8,400
2017-03-02 Hecht Curtis (See Remarks) Sale 550 12.00 6,600
2016-12-19 Molineaux Christopher (SR. VP, DEVELOPMENT) Option Ex 10,167 1.80 18,300
2016-12-19 Molineaux Susan (PRESIDENT AND CEO) Option Ex 21,933 1.80 39,479
2016-11-16 Gross Phillip Buy 500,000 3.15 1,575,000
2016-07-20 Molineaux Christopher (SR. VP, DEVELOPMENT) Option Ex 12,335 1.80 22,203
2016-07-20 Molineaux Susan (PRESIDENT AND CEO) Option Ex 29,385 1.36 39,963
2015-12-29 Bennett Mark K (SR. VP, RESEARCH) Option Ex 10,413 1.14 11,870
2015-12-21 Molineaux Christopher (SR. VP, DEVELOPMENT) Option Ex 10,167 1.80 18,300
2015-12-21 Molineaux Susan (PRESIDENT AND CEO) Option Ex 27,825 1.14 31,720
2015-11-16 Hecht Curtis (VP, BUS. & CORP. DEVELOPMENT) Sale 970 6.58 6,384
2015-09-23 Gross Phillip Buy 40,168 6.07 243,779
2015-09-22 Gross Phillip Buy 66,800 6.00 400,866
2015-09-04 Gross Phillip Buy 2,300 5.95 13,685
2015-09-03 Gross Phillip Buy 88,000 5.93 521,840
2015-08-28 Gross Phillip Buy 42,700 5.57 237,625
2015-08-27 Gross Phillip Buy 97,168 5.39 523,541
2015-08-26 Gross Phillip Buy 32,258 4.67 150,806
2015-08-20 Hecht Curtis (VP, BUS. & CORP. DEVELOPMENT) Option Ex 2,000 2.64 5,280
2015-07-14 Waddill William D. (SR. VP & CFO) Option Ex 13,125 2.64 34,650
2015-07-13 Molineaux Christopher (SR. VP, DEVELOPMENT) Option Ex 24,375 1.80 43,875
2015-07-13 Molineaux Susan (PRESIDENT AND CEO) Option Ex 76,287 1.14 86,967
2015-07-08 Bennett Mark K (SR. VP, RESEARCH) Option Ex 18,365 1.14 20,936
2014-12-16 Waddill William D. (SENIOR VP & CFO) Option Ex 6,797 4.92 33,441
2014-10-15 Gross Phillip Buy 38,000 7.03 266,950
2014-10-14 Gross Phillip Buy 55,000 7.00 384,725
2014-10-13 Gross Phillip Buy 88,700 6.94 615,578
2014-10-07 Atv Associates Viii, L.l.c. (10% Owner) Buy 300,000 10.00 3,000,000
2014-10-07 Morgenthaler Venture Partners Ix Lp (10% Owner) Buy 350,000 10.00 3,500,000
2014-10-07 Christoffersen Ralph E (Director) Buy 350,000 10.00 3,500,000
2014-10-07 George Jean (Director) Buy 300,000 10.00 3,000,000
2014-10-07 Pakianathan Deepika (Director) Buy 1,000,000 10.00 10,000,000
2014-10-01 Gross Phillip Buy 800,000 10.00 8,000,000

Insider trading activities including stock purchases, stock sales, and option exercises of CALA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Calithera Biosciences, Inc. (symbol CALA, CIK number 1496671) see the Securities and Exchange Commission (SEC) website.